| Analysis n= | Movement Biofeedback | Movement Biofeedback | End of treatment period |
---|---|---|---|---|
Group effect # | Group by time effect # | Mean (SD) | ||
Beta coefficient (95 % CI) | ||||
Beta coefficient (per 10Â days in the treatment period) (95 % CI) | ||||
Daily pain score | Sites = 8 | −0.62 (−1.25 to 0.01) | −0.051 (−0.075 to −0.026) | Movement Biofeedback Group |
(0 to 10 scale) | Clinicians = 8 |  |  | |
Participants = 98 | p = 0.053 | p < 0.001 | ||
Assessments = 6,036 | 4.26 (3.44 to 4.99) | |||
Guidelines-based Care Group4.54 (3.88 to 5.19) | ||||
LBP recurrence (difference in proportions of days with reported recurrence) | Sites = 8 | −0.018 (−0.129 to 0.093) | 0.003 (−0.002 to 0.008) | Movement Biofeedback Group |
Clinicians = 8 |  |  | ||
Participants = 100 | p = 0.752 | p = 0.263 | ||
Assessments = 5,999 | 0.230 (0.098 to 0.362) | |||
Guidelines-based Care Group | ||||
0.173 (0.070 to 0.276) | ||||
Analgesic use | Sites = 8 | 0.056 (−0.099 to 0.211) | −0.007 (−0.013 to −0.002) | Movement Biofeedback Group |
(difference in proportion of days with reported taking of analgesics) | Clinicians = 8 |  |  | |
Participants = 98 | p = 0.483 | p = 0.008 | 0.288 (0.137 to 0.440) | |
Assessments = 5,815 |  |  | ||
Guidelines-based Care Group | ||||
0.360 (0.109 to 0.612) | ||||
Number of pain and | Sites = 8 | 0.054 (0.003 to 0.107) | 0.004 (0.002 to 0.007) | Movement Biofeedback Group |
medication free days | Clinicians = 8 |  |  | 0.064 (−0.034 to 0.163) |
 |  |  |  | Guidelines-based Care Group |
 |  |  |  | 0.036 (−0.006 to 0.077) |